CTI BioPharma Corp. (NASDAQ: CTIC) announced today that it has received approval from the Israeli Ministry of Health (MOH) for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE